High-performance liquid chromatography determination of carvedilol in pig serum.
暂无分享,去创建一个
[1] Matthew W. Miller,et al. Pharmacokinetics of carvedilol after intravenous and oral administration in conscious healthy dogs. , 2005, American journal of veterinary research.
[2] G. De Nucci,et al. Quantification of carvedilol in human plasma by high-performance liquid chromatography coupled to electrospray tandem mass spectrometry: application to bioequivalence study. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[3] Sherry Wang,et al. Stereoselective analysis of carvedilol in human plasma using HPLC/MS/MS after chiral derivatization. , 2004, Journal of pharmaceutical and biomedical analysis.
[4] K. Stoschitzky,et al. Determination of Carvedilol in Human Plasma by High-Performance Liquid Chromatography Applying On-Line Deproteination and Column Switching , 2004 .
[5] J. Maček,et al. Liquid chromatographic determination of carvedilol in human plasma. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[6] S. Läer,et al. Determination of carvedilol in human cardiac tissue by high-performance liquid chromatography. , 2001, Journal of chromatographic science.
[7] L. Clohs,et al. Development of a capillary electrophoresis assay for the determination of carvedilol enantiomers in serum using cyclodextrins. , 2001, Journal of pharmaceutical and biomedical analysis.
[8] Vinod P. Shah,et al. Bioanalytical Method Validation—A Revisit with a Decade of Progress , 2000, Pharmaceutical Research.
[9] E. Duchoslav,et al. Automated liquid chromatographic/tandem mass spectrometric method for screening beta-blocking drugs in urine. , 2000, Journal of mass spectrometry : JMS.
[10] N. Hobara,et al. Rapid and simple micro-determination of carvedilol in rat plasma by high-performance liquid chromatography. , 1999, Journal of chromatography. B, Biomedical sciences and applications.
[11] Trefor Owen Morgan. Clinical Pharmacokinetics and Pharmacodynamics of Carvedilol , 1994, Clinical pharmacokinetics.
[12] P. Speight,et al. The Permeability of Human Oral Mucosa and Skin to Water , 1989, Journal of dental research.
[13] L. Cubeddu,et al. Liquid chromatographic assay and disposition of carvedilol in healthy volunteers. , 1986, Journal of pharmaceutical sciences.
[14] B. Kaufmann,et al. Stereoselective disposition of carvedilol in man after intravenous and oral administration of the racemic compound , 2005, European Journal of Clinical Pharmacology.
[15] 外間 惟夫. Influence of nicardipine and nifedipine on plasma carvedilol disposition after oral administration in rats , 2002 .
[16] P. Langguth,et al. Measurement of Carvedilol Enantiomers in Human Plasma and Urine Using S‐Naproxen Chloride for Chiral Derivatization , 1990, Archiv der Pharmazie.
[17] G. Kahn,et al. High-performance liquid chromatographic method for the simultaneous determination of the enantiomers of carvedilol and its O-desmethyl metabolite in human plasma after chiral derivatization. , 1989, Journal of chromatography.
[18] K. Strein,et al. Pharmacological Profile of Carvedilol, a Compound with &bgr;‐Blocking and Vasodilating Properties* , 1987, Journal of cardiovascular pharmacology.
[19] K. Reiff. High-performance liquid chromatographic method for the determination of carvedilol and its desmethyl metabolite in body fluids. , 1987, Journal of chromatography.